Description

DSIP – Delta Sleep-Inducing Peptide

DSIP 5 mg (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide first identified in the hypothalamus and associated with sleep regulation, stress modulation, and neuroendocrine balance. It has been widely studied for its ability to normalize sleep cycles, reduce corticotropin (ACTH) levels, and support homeostatic recovery under stress and fatigue conditions.

In preclinical models, DSIP has demonstrated effects on sleep quality, hormone secretion, pain modulation, and neuroprotection, making it an important molecule in sleep and neurological research.

Key Features & Research Applications

😴 Sleep Regulation:
Promotes natural slow-wave (deep) sleep phases and supports circadian rhythm stabilization.

🧠 Stress & Cortisol Modulation:
Influences hypothalamic-pituitary-adrenal (HPA) axis activity to reduce stress-related hormone secretion.

💪 Neuroendocrine Balance:
Normalizes hormonal release patterns, particularly growth hormone and luteinizing hormone rhythms.

🛡️ Neuroprotective Action:
May protect neural structures from oxidative and metabolic stress in preclinical studies.

💊 Potential Therapeutic Research:
Explored for its role in insomnia, chronic fatigue, anxiety, and mood regulation.

Product Details

• Name: DSIP (Delta Sleep-Inducing Peptide)

• Form: Lyophilized powder

• Sequence: Trp–Ala–Gly–Gly–Asp–Ala–Ser–Gly–Glu

• Molecular Formula: C₃₅H₄₈N₁₀O₁₅

• Molecular Weight: 849.8 g/mol

• Purity: ≥ 98% (HPLC verified)

• Dosage Strength: 5 mg per vial

• Appearance: White to off-white lyophilized powder

• Storage: Store in a cool, dry place; refrigerate (35.6–46.4°F) after reconstitution; avoid freeze–thaw cycles.

• Packaging: Sterile, sealed vial for laboratory research.

• Verification: Third-party tested for purity and identity.